Found: 6
Select item for more details and to access through your institution.
Nonalcoholic Fatty Liver Disease (NAFLD) as Model of Gut–Liver Axis Interaction: From Pathophysiology to Potential Target of Treatment for Personalized Therapy.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 12, p. 6485, doi. 10.3390/ijms22126485
- By:
- Publication type:
- Article
Gut Microbiota in Primary Sclerosing Cholangitis: From Prognostic Role to Therapeutic Implications.
- Published in:
- Digestive Diseases, 2024, v. 42, n. 4, p. 369, doi. 10.1159/000538493
- By:
- Publication type:
- Article
Characterization of the gut‐liver‐muscle axis in cirrhotic patients with sarcopenia.
- Published in:
- Liver International, 2021, v. 41, n. 6, p. 1320, doi. 10.1111/liv.14876
- By:
- Publication type:
- Article
PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2023.1326078
- By:
- Publication type:
- Article
PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease.
- Published in:
- Frontiers in Immunology, 2024, p. 01, doi. 10.3389/fimmu.2023.1326078
- By:
- Publication type:
- Article
Lynch Syndrome and Thyroid Nodules: A Single Center Experience.
- Published in:
- Genes, 2024, v. 15, n. 7, p. 859, doi. 10.3390/genes15070859
- By:
- Publication type:
- Article